Board Meeting26 Jun 2026, 02:58 pm
Entero Healthcare Approves ESOP Allotment & Director Reappointments
AI Summary
Entero Healthcare Solutions Ltd announced the outcome of its Board Meeting held on June 26, 2026. The Board approved the allotment of 1,475 equity shares to eligible employees under the Entero Employee Stock Option Plan 2023. Additionally, the Board approved the revised tenure for the reappointment of Independent Directors Mr. Rajesh Shashikant Dalal and Ms. Sandhya Gadkari Sharma for a second term of four years, subject to shareholder approval. The tenure of Mr. Sujesh Vasudevan remains unchanged. The meeting commenced at 1:00 p.m. IST and concluded at 2:45 p.m. IST.
Key Highlights
- 1,475 equity shares allotted under ESOP Plan 2023.
- Independent Directors' reappointment tenure revised.
- Shareholder approval needed for director reappointments.
- Mr. Sujesh Vasudevan's director tenure remains unchanged.
Price Impact
More from ENTERO